Related Experiment Videos
Neonatal subependymal giant cell astrocytoma
Azedine Medhkour1, David Traul, Muhammad Husain
1Division of Neurosurgery, Medical College of Ohio, Toledo 43614-2598, USA. amedhkour@mco.edu
Pediatric Neurosurgery
|June 8, 2002
Summary
A rare, aggressive neonatal subependymal giant cell astrocytoma (SEGCA) in a 5-month-old with tuberous sclerosis complex (TSC) led to obstructive hydrocephalus and intractable seizures, despite interventions. This case highlights management challenges and the need for further research.
Area of Science:
- Neuro-oncology
- Pediatric Neurology
- Genetics
Background:
- Subependymal giant cell astrocytoma (SEGCA) is typically a benign, slow-growing glial tumor associated with tuberous sclerosis complex (TSC).
- Aggressive neonatal presentations of SEGCA are exceptionally rare.
Observation:
- A 5-month-old infant with TSC presented with a left frontal lobe cystic mass and multiple periventricular masses.
- Initial conservative management was followed by readmission due to intractable seizures, tumor growth, and obstructive hydrocephalus.
Findings:
- Despite surgical interventions, the infant's intracranial lesions proved fatal.
- This case illustrates the aggressive potential of neonatal SEGCA in the context of TSC.
Implications:
- Highlights the challenges in managing aggressive neonatal SEGCA.
- Emphasizes the critical need for further research, including genetic studies, to elucidate SEGCA pathophysiology.
- Suggests potential for improved therapeutic strategies through a deeper understanding of the disease.